Expression of an efficient small molecular weight tumour necrosis factor/lymphotoxin antagonist.

Expression of an efficient small molecular weight tumour necrosis factor/lymphotoxin antagonist.

TNF-alpha and lymphotoxin are proinflammatory cytokines that are non-homologous in sequence, have similar homotrimeric structure and they exert their biological activity by aggregating two types of shared cell surface receptors. The natural inhibitors of TNF and lymphotoxin are the shed extracellula...

Bibliográfalaš dieđut
Váldodahkkit:	Neve, R, Kissonerghis, M, Clark, J, Feldmann, M, Chernajovsky, Y
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	1996

Geahča maid

Comparison of patterns of expression of tumour necrosis factor, lymphotoxin and interleukin-6 mRNA.
Dahkki: Turner, M, et al.
Almmustuhtton: (1988)

HLA class II induction in human islet cells by interferon-gamma plus tumour necrosis factor or lymphotoxin.
Dahkki: Pujol-Borrell, R, et al.
Almmustuhtton: (1987)

Characterization of ligand binding by the human p55 tumour-necrosis-factor receptor. Involvement of individual cysteine-rich repeats.
Dahkki: Corcoran, A, et al.
Almmustuhtton: (1994)

Prospects for the development of small molecular weight compounds to replace anti-tumour necrosis factor biological agents.
Dahkki: Foxwell, B, et al.
Almmustuhtton: (2003)

Tumor necrosis factor and lymphotoxin-alpha polymorphisms and severe malaria in African populations.
Dahkki: Clark, T, et al.
Almmustuhtton: (2009)

The tumor necrosis factor superfamily members TNFSF14 (LIGHT), lymphotoxin β and lymphotoxin β receptor interact to regulate intestinal inflammation
Dahkki: Giles, DA, et al.
Almmustuhtton: (2018)

The murine p75 TNF receptor promoter region: DNA sequence and characterization of a cis-acting silencer.
Dahkki: Kissonerghis, M, et al.
Almmustuhtton: (1999)

The Tumor Necrosis Factor Superfamily Members TNFSF14 (LIGHT), Lymphotoxin β and Lymphotoxin β Receptor Interact to Regulate Intestinal Inflammation
Dahkki: Daniel A. Giles, et al.
Almmustuhtton: (2018-11-01)

Tumour necrosis factor synergises with gamma interferon on the induction of mRNA for DR alpha chain on thyrocytes from Graves' disease and non toxic goitre.
Dahkki: Kissonerghis, A, et al.
Almmustuhtton: (1989)

Arming ColoAd1 with tumor necrosis factor alpha and lymphotoxin alpha
Dahkki: Koelen, J
Almmustuhtton: (2015)

Lymphotoxin expression in human and murine renal allografts.
Dahkki: Harald Seeger, et al.
Almmustuhtton: (2018-01-01)

Cloning, expression and cross-linking analysis of the murine p55 tumor necrosis factor receptor.
Dahkki: Barrett, K, et al.
Almmustuhtton: (1991)

The effect of HLA-DR on susceptibility to rheumatoid arthritis is influenced by the associated lymphotoxin alpha-tumor necrosis factor haplotype.
Dahkki: Newton, J, et al.
Almmustuhtton: (2003)

DNA sequence polymorphism at the human tumor necrosis factor (TNF) locus. Numerous TNF/lymphotoxin alleles tagged by two closely linked microsatellites in the upstream region of the lymphotoxin (TNF-beta) gene.
Dahkki: Nedospasov, SA, et al.
Almmustuhtton: (1991)

Genomic organization and phylogenetic utility of deer mouse (<it>Peromyscus maniculatus</it>) lymphotoxin-alpha and lymphotoxin-beta
Dahkki: Prescott Joseph, et al.
Almmustuhtton: (2008-10-01)

Association of Tumor Necrosis Factor Alpha and Lymphotoxin Alpha Gene Polymorphisms with the Presence of Chronic Obstructive Pulmonary Disease
Dahkki: Amira P Tarigan, et al.
Almmustuhtton: (2015-12-01)

What is the mechanism of action of anti-tumour necrosis factor-alpha antibody in rheumatoid arthritis?
Dahkki: Feldmann, M
Almmustuhtton: (1996)

Inhibition of transfer of collagen-induced arthritis into SCID mice by ex vivo infection of spleen cells with retroviruses expressing soluble tumor necrosis factor receptor.
Dahkki: Chernajovsky, Y, et al.
Almmustuhtton: (1995)

Lymphotoxin-sensitive microenvironments in homeostasis and inflammation
Dahkki: Bryant eBoulianne, et al.
Almmustuhtton: (2012-07-01)

Family-based analysis of tumor necrosis factor and lymphotoxin-alpha tag polymorphisms with type 1 diabetes in the population of South Croatia.
Dahkki: Boraska, V, et al.
Almmustuhtton: (2009)

Metabolic activation and colitis pathogenesis is prevented by lymphotoxin β receptor expression in neutrophils
Dahkki: Riffelmacher, T, et al.
Almmustuhtton: (2021)

Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
Dahkki: Corcoran, A, et al.
Almmustuhtton: (1998)

STRUCTURE-FUNCTION STUDIES ON THE EXTRACELLULAR DOMAIN OF THE HUMAN P55 TNF RECEPTOR
Dahkki: Corcoran, A, et al.
Almmustuhtton: (1992)

Functional characterization of rs2229094 (T>C) polymorphism in the tumor necrosis factor locus and lymphotoxin alpha expression in human retina: the Retina 4 project
Dahkki: Pastor-Idoate S, et al.
Almmustuhtton: (2017-05-01)

Gene therapy for chronic relapsing experimental allergic encephalomyelitis using cells expressing a novel soluble p75 dimeric TNF receptor.
Dahkki: Croxford, J, et al.
Almmustuhtton: (2000)

Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha.
Dahkki: Williams, R, et al.
Almmustuhtton: (2000)

Selective immunosuppression of tumour necrosis factor-alpha in rheumatoid arthritis.
Dahkki: Brennan, F, et al.
Almmustuhtton: (1995)

Tumour necrosis factor-alpha expression in tumour islets confers a survival advantage in non-small cell lung cancer
Dahkki: Shikotra Aarti, et al.
Almmustuhtton: (2010-06-01)

Localization of the genes for tumor necrosis factor and lymphotoxin between the HLA class I and III regions by field inversion gel electrophoresis.
Dahkki: Ragoussis, J, et al.
Almmustuhtton: (1988)

Overexpression of lymphotoxin in T cells induces fulminant thymic involution.
Dahkki: Heikenwalder, M, et al.
Almmustuhtton: (2008)

Tumour necrosis factor alpha as a therapeutic target for immune-mediated inflammatory diseases.
Dahkki: Taylor, P, et al.
Almmustuhtton: (2004)

Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha.
Dahkki: Buchan, G, et al.
Almmustuhtton: (1988)

The effects of pressure on chondrocyte tumour necrosis factor receptor expression.
Dahkki: Westacott, C, et al.
Almmustuhtton: (2002)

Tumour necrosis factor.
Dahkki: Van Der Merwe, P
Almmustuhtton: (1988)

Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines.
Dahkki: Gibbons, D, et al.
Almmustuhtton: (1994)

Soluble lymphotoxin is an important effector molecule in GVHD and GVL.
Dahkki: Markey, K, et al.
Almmustuhtton: (2010)

Lymphotoxin, but not TNF, is required for prion invasion of lymph nodes.
Dahkki: Tracy O'Connor, et al.
Almmustuhtton: (2012-01-01)

Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)
Dahkki: Maini, R, et al.
Almmustuhtton: (1995)

Inhibition of Immune Complex-Induced Inflammation by A small Molecular Weight Selectin Antagonist
Dahkki: X. Nair, et al.
Almmustuhtton: (1994-01-01)

The role of receptors for tumour necrosis factor-alpha in the induction of human polymorphonuclear neutrophil chemiluminescence.
Dahkki: Zeman, K, et al.
Almmustuhtton: (1996)